Faeth Therapeutics raised $25 million in a funding round led by S2G Ventures, bringing total funding to $92 million to advance its PIKTOR phase 2 trial for endometrial cancer.
Amount Raised
$25 Million
Round Type
Funding Round
AustinBiotechnologyHealth CareMedicalTherapeuticsresearchInvestors
Description
Faeth Therapeutics announces a $25 million strategic raise, bringing total capital raised to $92 million. The funding will advance the lead PIKTOR regimen in endometrial cancer, which has shown an 80% response rate. The phase 2 trial is now enrolling patients. Notable participants in the funding include S2G Ventures and several existing investors.
Who to call at Faeth Therapeutics, and when
A new round usually means Faeth Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Faeth Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Faeth Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Faeth Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Faeth Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Faeth Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.